Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study

To evaluate the performance of aspartate transaminase-to-platelet ratio index (APRI) and fibrosis index based on four factors (FIB-4) to predict significant fibrosis and cirrhosis in hepatitis B virus e antigen (HBeAg)-negative chronic hepatitis B (CHB) patients with alanine transaminase (ALT) ≤ twi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qiang, Ren, Xiaojing, Lu, Chuan, Li, Weixia, Huang, Yuxian, Chen, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371450/
https://www.ncbi.nlm.nih.gov/pubmed/28328813
http://dx.doi.org/10.1097/MD.0000000000006336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371450/
https://www.ncbi.nlm.nih.gov/pubmed/28328813
http://dx.doi.org/10.1097/MD.0000000000006336

Ejemplares similares